Alopecia areata

Current Directions in Autoimmunity

Volumn 10, Issue , 2008, Pages 280-312

  King Jr , L E ^a   McElwee, K J ^b   Sundberg, J P ^a,c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUS;

ALOPECIA AREATA; ANIMAL; ANTIBODY SPECIFICITY; AUTOIMMUNE DISEASE; CELLULAR IMMUNITY; DISEASE MODEL; GENETICS; HUMAN; IMMUNOLOGY; MOUSE; PATHOLOGY; REVIEW;

ALOPECIA AREATA; ANIMALS; AUTOIMMUNE DISEASES; DISEASE MODELS, ANIMAL; HUMANS; IMMUNITY, CELLULAR; MICE; ORGAN SPECIFICITY;

EID: 49049102806     PISSN: 14222132     EISSN: 16622936     Source Type: Book Series    
DOI: 10.1159/000131749     Document Type: Review

References (213)

1. Muller SA, Winkelmann RK: Alopecia areata: an evaluation of 736 patients. Arch Dermatol 1963;88:290-297.
2. Safavi KH, Muller SA, Suman VJ, Moshell AN, Melton LJ: Incidence of alopecia areata in Olmstead County, Minnesota 1975-1989. Mayo Clin Proc 1995;70:628-633.
3. Wang S-J, Shohat T, Vadheim C, Shellow W, Edwards J, Rotter JI: Increased risk for type I (insulin-dependent) diabetes in relatives of patients with alopecia areata (AA). Am J Med Genet 1994;51:234-239.
4. Cunliffe WJ, Hall R, Stevenson CJ, Weightman D: Alopecia areata, thyroid disease and autoimmunity. Br J Dermatol 1969;81:877-881.
5. Milgraum SS, Mitchell AJ, Bacon GE, Rasmussen JE: Alopecia areata, endocrine function, and autoantibodies in patients 16 years of age or younger. J Am Acad Dermatol 1987;17:57-61.
6. Shellow WV, Edwards JE, Koo JY: Profile of alopecia areata: a questionaire analysis of patient and family. Int J Dermatol 1992;31:186-189.
7. Puavilai S, Puavilai G, Charuwichitratana S, Sakuntabhai A, Sriprachya-Anunt S: Prevalence of thyroid diseases in patients with alopecia areata. Int J Dermatol 1994;33:632-633.
8. Kurtev A, Iliev E: Thyroid autoimmunity in children and adolescents with alopecia areata. Int J Dermatol 2005;44:457-461.
9. Liu JB, Li M, Yang S, Gui JP, Wang HY, Du WH, Zhao XY, Ren YQ, Zhu YG, Zhang XJ: Clinical profiles of vitiligo in China: an analysis of 3,742 patients. Clin Exp Dermatol 2005;30:327-331.
10. Goh C, Finkel M, Christos PJ, Sinha AA: Profile of 513 patients with alopecia areata: associations of disease subtypes with atopy, autoimmune disease and positive family history. J Eur Acad Dermatol Venereol 2006;20:1055-1060.
11. Schallreuter KU, Lemke R, Brandt O, Schwartz R, Westhofen M, Montz R, Berger J: Vitiligo and other diseases: coexistence or true association? Hamburg study of 321 patients. Dermatology 1994;188:269-275.
12. Sperling LC: Alopecias; in Bolognia JL, Jorizzo JL, Rapini P: Dermatology. Ed 2, Mosby Elsevier, 2008, pp 998-1007.
13. Ikeda T: A new classification of alopecia areata. Dermatologica 1965;131:421-445.
14. Penders AJ: Alopecia areata and atopy. Dermatologica 1968;136:395-399.
15. de Waard-van der Spek FB, Oranje AP, de Raeymaecker DM, Peereboom-Wynia JD: Juvenile versus maturity-onset alopecia areata - a comparative retrospective clinical study. Clin Exp Dermatol 1989;14:429-433.
16. Weise K, Kretzschmar L, John SM, Hamm H: Topical immunotherapy in alopecia areata: anamnestic and clinical criteria of prognostic significance. Dermatology 1996;192:129-133.
17. Sabouraud R: Sur les origines de la pelade. Ann Dermatol Syphiligr (Paris) 1896;3:253-277.
18. Barber H: Alopecia areata. Br J Dermatol Syphilis 1921;33:1-14.
19. Bowen J: Two epidemics of alopecia areata in an asylum for girls. J Cutaneous Genito-Urin Dis 1899;17:399-404.
20. Fox TC: On a small epidemic of an areate alopecia. Br J Dermatol 1913;25:51-56.
21. Davis H: Epidemic alopecia areata. Br J Dermatol 1914;26:207-210.
22. Roxburgh AC: The aetiology of alopecia areata and its relationship to vitiligo and scleroderma. Br J Dermatol Syphilis 1929;41:351-363.
23. Ormsby OS: Diseases of the skin, ed 7. London, Henry Kimpton, 1948.
24. Ikeda T: Produced alopecia areata based on the focal infection theory and mental motion theory. Dermatologica 1967;134:1-11.
25. Skinner RB, Light WH, Bale GF, Rosenberg EW, Leonardi C: Alopecia areata and presence of cytomegalovirus DNA. J Am Med Assoc 1995;273:1419-1420.
26. Skinner RB, Light WH, Leonardi C, Bale GF, Rosenberg EW: A molecular approach to alopecia areata. J Invest Dermatol 1995;104(suppl):3S-4S.
27. Hernandez MJG, Torres MJ, Palomares JC, Rodriguez-Pichardo A, Aznar J, Camacho F: No evidence of cytomegalovirus DNA in alopecia areata. J Invest Dermatol 1998;110:185.
28. Tosti A, Placa ML, Placucci, Gentilomi G, Venturoli S, Zerbini M, Musiani M: No correlation between cytomegalovirus and alopecia areata. J Invest Dermatol 1996;107:443.
29. Jackow C, Puffer N, Hordinsky M, Nelson J, Tarrand J, Duvic M: Alopecia areata and cytomegalovirus infection in twins: genes versus environment? J Am Acad Dermatol 1998;38:418-425.
30. Offidani A, Amerio P, Bernardini ML, Fliciani C, Bossi G: Role of cytomegalovirus replication in alopecia areata pathogenesis. J Cutan Med Surg 2000;4:63-65.
31. Freshwater D: Alopecia areata. Practitioner 1915;95:796-806.
32. Joseph M: Experimentelle Untersuchungen über die Ätiologie der Alopecia areata. Monatsh Prakt Dermatol 1886;5:483-489.
33. Slominski A: Neuroendocrine system of the skin. Dermatology 2005;211:199-208.
34. Kingsbury J: Three cases of alopecia areata associated with ametropia. J Cut Dis 1909;27:211.
35. Hordinsky MK, Kennedy W, Wendelschafer-Crabb G, Lewis S: Structure and function of cutaneous nerves in alopecia areata. J Invest Dermatol 1995;104(suppl):28S-29S.
36. Hordinsky MK, Ericson ME: Relationship between follicular nerve supply and alopecia. Dermatol Clin 1996;14:651-660.
37. Hordinsky MK: Alopecia areata; in Olson EA: Disorders of Hair Growth. New York, McGraw-Hill, 1994, pp 195-222.
38. Adamson HG: Modern Views Upon the Significance of Skin Eruptions. London, John Bale & Sons, 1912.
39. Brown WH: The aetiology of alopecia areata and its relationship to vitiligo and possibly scleroderma. Br J Dermatol Syphilis 1929;41:299-323.
40. Dixon WE: Thallium. Proc R Soc Med 1927;20:1197-1200.
41. Meachen GN, Provis FL: Case of alopecia areata et totalis. Br J Dermatol 1912;24:272-274.
42. Sabouraud R: Nouvelles recherches sur l'etiologie de la pelade (pelade et menopause). Ann Dermatol Syphiligr (Paris) 1913;5:88-97.
43. Sabouraud R: Pelade et goitre exohthalmique. Ann Dermatol Syphiligr (Paris) 1913;5:140-148.
44. Levy-Franckel A, Juster E: La pelade. J Med Paris 1925;44:631-635.
45. Sharma VK, Sialy R, Kumar B, Gupta S: Evaluation of thyroid function in north Indians with alopecia areata: response to intravenous injection of 100 micrograms thyrotropin releasing hormone (TRH). J Dermatol 1999;26:339-342.
46. Collins SM, Dominguez M, Ilmarinen T, Costigan C, Irvine AD: Dermatological manifestations of autoimmune polyendocrinopathy-candidiasis- ectodermal dystrophy syndrome. Br J Dermatol 2006;154:1088-1093.
47. Giovannini S: Recherches sur l'histologie pathologique de la pelade. Ann Dermatol Syhiligr (Paris) 1891;3:921-957.
48. Van Scott EJ: Morphologic changes in pilosebaceous units and anagen hairs in alopecia areata. J Invest Dermatol 1958;31:35-43.
49. Paus R, Slominski A, Czarnetzki BM: Is alopecia areata an autoimmune-response against melanogenesis-related proteins exposed by abnormal MHC class I expression in the anagen hair bulb? Yale J Biol Med 1993;66:541-554.
50. McDonagh AJ, Messenger AG: The aetiology and pathogenesis of alopecia areata. J Dermatol Sci 1994;7(suppl):S125-S135.
51. McDonagh AJ, Messenger AG: The pathogenesis of alopecia areata. Dermatol Clin 1996;14:661-670.
52. Bystryn J-C, Tamesis J: Immunologic aspects of hair loss. J Invest Dermatol 1991;96:88S-89S.
53. McElwee KJ, Tobin DJ, King LE, Sundberg JP: Alopecia areata: an autoimmune disease? Exp Dermatol 1999;8:371-379.
54. Hordinsky MK: Alopecia areata: pathophysiology and latest developments. J Cutan Med Surg 1999;3(suppl 3):S28-S30.
55. Randall VA: Is alopecia areata an autoimmune disease? Lancet 2001;358:1922-1924.
56. Perret C, Wiesner-Menzel L, Happle R: Immunohistochemical analysis of T-cell subsets in the peribulbar and intrabulbar infiltrates of alopecia areata. Acta Derm Venereol 1984;64:26-30.
57. Ranki A, Kianto U, Kanerva L, Tolvanen E, Johansson E: Immunohistochemical and electron microscopic characterization of the cellular infiltrate in alopecia (areata, totalis, and universalis). J Invest Dermatol 1984;83:7-11.
58. Zhang JG, Oliver RF: Immunohistochemical study of the development of the cellular infiltrate in the pelage follicles of the DEBR model for alopecia areata. Br J Dermatol 1994;130:405-414.
59. Sundberg JP, Cordy WR, King LE: Alopecia areata in aging C3H/HeJ mice. J Invest Dermatol 1994;102:847-856.
60. Wiesner-Menzel L, Happle R: Intrabulbar and peribulbar accumulation of dendritic OKT 6-positive cells in alopecia areata. Arch Dermatol Res 1984;276:333-334.
61. Paus R: Immunology of the hair follicle; in Bos JD: Skin Immune System (SIS): Cutaneous Immunology and Clinical Immunodermatology, ed 2. Boca Raton, CRC Press, 1997, pp 377-398.
62. Barker CF, Billingham RE: Immunologically privileged sites. Adv Immunol 1977;25:1-54.
63. Westgate GE, Craggs RI, Gibson WT: Immune privilege in hair growth. J Invest Dermatol 1991;97:417-420.
64. Messenger AG, Bleehen SS: Expression of HLA-DR by anagen hair follicles in alopecia areata. J Invest Dermatol 1985;85:569-572.
65. Khoury EL, Price VH, Greenspan JS: HLA-DR expression by hair follicle keratinocytes in alopecia areata: evidence that it is secondary to the lymphoid infiltration. J Invest Dermatol 1988;90:193-200.
66. Brocker E-B, Echternacht-Happle K, Hamm H, Happle R: Abnormal expression of class I and class II major histocompatibility antigens in alopecia areata: modulation by topical immunotherapy. J Invest Dermatol 1987;88:564-568.
67. Lu W, Shapiro J, Yu M, Barekatain A, Lo B, Finner A, McElwee K. Alopecia areata: pathogenesis and potential for therapy. Expert Rev Mol Med 2006;20:1-19.
68. McDonagh AJG, Snowden JA, Stierle C, Elliott K, Messenger AG: HLA and ICAM-1 expression in alopecia areata in vivo and in vitro: the role of cytokines. Br J Dermatol 1993;129:250-256.
69. Nickoloff BJ, Griffiths CEM: Aberrant intercellular adhesion molecule-1 (ICAM-1) expression by hair-follicle epithelial cells and endothelial leukocyte adhesion molecule-1 (ELAM-1) by vascular cells are important adhesion-molecule alterations in alopecia areata. J Invest Dermatol 1991;96:91S-92S.
70. Hoffmann R, Wenzel E, Huth A, van der Steen P, Schaufele M, Henninger H-P, Happle R: Cytokine mRNA levels in alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone. J Invest Dermatol 1994;103:530-533.
71. Tobin DJ, Orentreich N, Fenton DA, Bystryn J-C: Antibodies to hair follicles in alopecia areata. J Invest Dermatol 1994;102:721-724.
72. Tobin DJ, Orentreich N, Bystryn J-C: Autoantibodies to hair follicles in normal individuals. Arch Dermatol 1994;130:395-396.
73. Tobin DJ: Alopecia areata is associated with antibodies to hair follicle-specific antigens located predominantly in the proliferative region of hair follicles; in van Neste D, Randall V: Hair Research for the Next Millennium. Elsevier, Amsterdam, 1996, pp 237-241.
74. Tobin DJ, Hann S-K, Song M-S, Bystryn J-C: Hair follicle structures targeted by antibodies in alopecia areata. Arch Dermatol 1997;133:57-61.
75. Tobin DJ, Sundberg JP, King LE, Boggess D, Bystryn J-C: Autoantibodies to hair follicles in C3H/HeJ mice with alopecia areata-like hair loss. J Invest Dermatol 1997;109:329-333.
76. McElwee KJ, Pickett P, Oliver RF: Hair follicle autoantibodies in DEBR rat sera. J Invest Dermatol 1995;104(suppl):34S-35S.
77. McElwee KJ, Pickett P, Oliver RF: The DEBR rat, alopecia areata and autoantibodies to the hair follicle. Br J Dermatol 1996;134:55-62.
78. McElwee KJ, Drummond S, Oliver RF: Hair follicle specific autoantibodies associated with alopecia areata in sera from the DEBR rat model and humans; in van Neste D, Randall V: Hair Research for the Next Millennium. Elsevier, Amsterdam, 1996, pp 253-257.
79. Tan RSH, Samman PD: Thymoma, acquired hypogammaglobulinemia, lichen planus, alopecia areata. Proc R Soc Med 1974;67:196-198.
80. McElwee K, Boggess D, Miller J, King L, Sundberg J: Spontaneous alopecia areata-like hair loss in one congenic and seven inbred laboratory mouse strains. J Invest Dermatol Symp Proc 1999;4:202-206.
81. Carroll J, McElwee KJ, King LE, Byrne MC, Sundberg JP: Gene array profiling and immunomodulation studies define a cell mediated immune response underlying the pathogenesis of alopecia areata in a mouse model and humans. J Invest Dermatol 2002;119:392-402.
82. Grabar P: Autoantibodies and the physiological role of immunoglobulins. Immunol Today 1983;4:337-340.
83. Maran R, Dueymes M, Corre RL, Renaudineau Y, Shoenfeld Y, Youinou P: IgG subclasses of human autoantibodies. Ann Med Intern 1997;148:29-38.
84. El-Roiey A, Gross WL, Ludemann J, Isenberg DA, Shoenfeld Y: Preferential secretion of a common anti-DNA idiotype (16/6 Id) and anti-polynucleotide antibodies by normal mononuclear cells following stimulation with Klebsiella pneumoniae. Immunol Lett 1986;12:313-319.
85. Gilhar A, Landau M, Assy B, Shalaginov R, Serafimovich S, Kalish RS: Melanocyte-associated T cell epitopes can function as autoantigens for transfer of alopecia areata to human scalp explants on Prkdcscid mice. J Invest Dermatol 2001;117:1357-1362.
86. Colombe BW, Price VH, Khoury EL, Garovoy MR, Lou CD: HLA class II antigen associations help to define two types of alopecia areata. J Am Acad Dermatol 1995;33:757-764.
87. van der Steen P, Traupe H, Happle R, Boezeman J, Sträter R, Hamm H: The genetic risk for alopecia areata in first degree relatives of severely affected patients: an estimate. Acta Derm Venereol 1992;72:373-375.
88. Green J, Sinclair RD: Genetics of alopecia areata. Australas J Dermatol 2000;41:213-318.
89. Barsky S, Gigli I: Alopecia areata in twins. Arch Dermatol 1961;83:224-225.
90. Bonjean M, Prime A, Avon P: Pelade chez deux jumeaux homozygotes (sic). Lyon Med 1968;219:1852-1853.
91. Cole GW, Herzlinger D: Alopecia universalis in identical twins. Int J Dermatol 1984;23:283.
92. Hendren S: Identical alopecia areata in identical twins. Arch Dermatol 1949;60:793-795.
93. Weidman AI, Zion LS, Mamelok AE: Alopecia areata occurring simultaneously in identical twins. Arch Dermatol 1956;74:424-426.
94. Werth VP, White WL, Sanchez MR, Franks AG: Incidence of alopecia areata and lupus erythematosus. Arch Dermatol 1992;128:368-371.
95. Insler MS, Helm CJ: Alopecia areata including the cilia and eyebrows of two sisters. Ann Ophthalmol 1989;21:451-453.
96. Hordinsky MK, Hallgren H, Nelsen D, Filipovich AH: Familial alopecia areata. HLA antigens and autoimmunity formation in an American family. Arch Dermatol 1984;120:464-468.
97. Sharma VK, Dawn G, Kumar B: Profile of alopecia areata in Northern India. Int J Dermatol 1996;35:22-27.
98. Du Vivier A, Munro DD: Alopecia areata, autoimmunity, and Down's syndrome. Br Med J 1975;1:191-192.
99. Carter DM, Jegasothy BV: Alopecia areata and Down syndrome. Arch Dermatol 1976;112:1397-1399.
100. Tazi-Ahnini R, Cork MJ, Gawkrodger DJ, Birch MP, Wengraf D, McDonagh AJG, Messenger AG: Role of the autoimmune regulator (AIRE) gene in alopecia areata: strong association of a potentially functional AIRE polymorphism with alopecia universalis. Tissue Antigens 2002;60:489-495.
101. Theofilopoulos AN: The basis of autoimmunity. Part II. Genetic predisposition. Immunol Today 1995;16:150-159.
102. Blum A, Miller H: The major histocompatibility complex and inflammation. Southern Med J 2000;93:169-171.
103. Campbell RD, Milner CM: MHC genes in autoimmunity. Curr Opin Immunol 1993;5:887-893.
104. Corzo D, Salazar M, Granja CB, Yunis EJ: Advances in HLA genetics. Exp Clin Immunogenet 1995;12:156-170.
105. Tomlinson IP, Bodmer WF: The HLA system and the analysis of multifactorial genetic disease. Trends Genet 1995;11:493-498.
106. Thompson G: HLA disease associations: models for the study of complex human genetic disorders. Crit Rev Clin Lab Sci 1995;32:183-219.
107. Welsh EA, Clark HH, Epstein SZ, Reveille JD, Duvic M: Human leukocyte antigen-DQB01 *03 alleles are significantly associated with alopecia areata. J Invest Dermatol 1994;103:758-763.
108. Morling N, Frentz G, Fugger L, Georgsen J, Jakobsen B, Odum N, Svejgaard A: DNA polymorphism of HLA class II genes in alopecia areata. Dis Markers 1991;9:35-42.
109. Kavak A, Baykal C, Ozarmagan G, Akar U: HLA and alopecia areata. Int J Dermatol 2000;39:589-592.
110. Kianto U, Reunala T, Karvonen J, Lassus A, Tiilikainen A: HLA-B12 in alopecia areata. Arch Dermatol 1977;113:1716.
111. Kuntz BM, Selzle D, Braun-Falco O, Scholz S, Albert ED: HLA antigens in alopecia areata. Arch Dermatol 1997;113:1717.
112. Hacham-Zadeh S, Brautbar C, Cohen C, Cohen T: HLA and alopecia areata in Jerusalem. Tissue Antigens 1981;18:71-74.
113. Averbakh EV, Pospelo LE: HLA antigens in patients with alopecia areata. Vestn Dermatol Venerol 1986;1:24-26.
114. Frentz G, Thomsen K, Jakobsen BK, Svejgaard A: HLA-DR4 in alopecia areata. J Am Acad Dermatol 1986;14:129-130.
115. Orecchia G, Belvedere MD, Martinetti M, Capelli E, Rabbiosi G: Human leukocyte antigen region involvement in the genetic predisposition to alopecia areata. Dermatologica 1987;175:10-14.
116. Duvic M, Hordinsky MK, Fiedler VC, O'Brien WR, Young R, Reveille JD: HLA-D locus associations in alopecia areata: DRw52a may confer disease resistance. Arch Dermatol 1991;127:64-68.
117. Duvic M, Welsh EA, Jackow C, Papadopoulos E, Reveille JD, Amos C: Analysis of HLA-D locus alleles in alopecia areata patients and families. J Invest Dermatol 1995;104(suppl):5S-6S.
118. Colombe BW, Price VH, Khoury EL, Lou CD: HLA class II alleles in long-standing alopecia totalis/alopecia universalis and long-standing patchy alopecia areata differentiate these two clinical groups. J Invest Dermatol 1995;104(suppl):4S-5S.
119. Barahmani N, deAndrade M, Slusser JP, Zhang Q, Duvic M: Major histocompatibility complex class I chain-related gene A polymorphisms and extended haplotypes are associated with familial alopecia areata. J Invest Dermatol 2006;126:74-78.
120. Hang L, Nakamura RM: Current concepts and advances in clinical laboratory testing for autoimmune diseases. Crit Rev Clin Lab Sci 1997;34:275-311.
121. Martinez-Mir A, Zlotogorski A, Gordon D, Petukhova L, Mo J, Gilliam TC, Londono D, Haynes C, Ott J, Hordinsky M, Nanova K, Norris D, Price V, Duvic M, Christiano AM: Genomewide scan for linkage reveals evidence of several susceptibility loci for alopecia areata. Am J Hum Genet 2007;80:316-328.
122. Gollinck H, Orfanos CE: Alopecia areata: pathogenesis and clinical picture; in Orfanos CE, Happle R: Hair and Hair Diseases. Berlin, Springer-Verlag, 1990, pp 529-569.
123. Price VH, Khoury EL: Alopecia areata. Prog Dermatol 1991;25:1-7.
124. Conroy JD: Alopecia areata; in Andrews EJ, Ward BC, Altman NH: Spontaneous Animal Models of Human Disease. New York, Academic Press, 1979, pp 30-31.
125. Muller GH, Kirk RW, Scott DW: Small Animal Dermatology, ed 3. Philadelphia, WB Saunders, 1983.
126. Paradis M, Fecteau G, Scott DW: Alopecia areata (pelade) in a cow. Can Vet J 1988;29:727-729.
127. Scott DW, Guard CL: Alopecia areata in a cow. Agri-Practice 1998;9:16-19.
128. Sundberg JP, Oliver RF, McElwee KJ, King LE: Alopecia areata in humans and other mammalian species. J Invest Dermatol 1995;104:32S-33S.
129. Smyth JR, McNeil M: Alopecia areata and universalis in the Smyth chicken model for spontaneous autoimmune vitiligo. J Invest Dermatol Symp Proc 1999;4:211-215.
130. Michie HJ, Jahoda CAB, Oliver RF, Poulton TA: Immunobiological studies on the alopecic (DEBR) rat. Br J Dermatol 1990;123:557-567.
131. Michie HJ, Jahoda CAB, Oliver RF, Johnson BE: The DEBR rat: an animal model of human alopecia areata. Br J Dermatol 1991;125:94-100.
132. Oliver R, Jahoda CAB, Horne KA, Michie HJ, Poulton T, Johnson BE: The DEBR rat model for alopecia areata. J Invest Dermatol 1991;96:97S.
133. Yanagisawa H, Richardson JA, Taurog JD, Hammer RE: Characterization of psoriasiform and alopecic skin lesions in HLA-B27 transgenic rats. Am J Pathol 1995;147:995-964.
134. Sundberg JP, Vallee CM, King LE: Alopecia areata in aging C3H/HeJ mice; in Sundberg JP: Handbook of Mouse Mutations with Skin and Hair Abnormalities: Animal Models and Biomedical Tools. Boca Raton, CRC Press, 1994, pp 499-505.
135. McElwee KJ, Boggess D, King LE, Sundberg JP: Experimental induction of alopecia areata-like hair loss in C3H/HeJ mice using full-thickness skin grafts. J Invest Dermatol 1998;111:797-803.
136. Friedman PS: Clinical and immunological association of alopecia areata. Semin Dermatol 1985;4:9-13.
137. Tobin DJ, Fenton DA, Kendall MD: Ultrastructural observations on the hair bulb melanocytes and melanosomes in acute alopecia areata. J Invest Dermatol 1990;94:803-807.
138. Tobin DJ, Fenton DA, Kendall MD: Cell degeneration in alopecia areata: an ultrastructural study. Am J Dermatopathol 1991;13:248-256.
139. Shapiro J, Sundberg JP, Bissonnette R, McElwee KJ, McLean DI, Carroll JM, Oliver RF, Tang L, Lui H: Alopecia areata-like hair loss in C3H/HeJ mice and DEBR rats can be reversed using topical diphencyprone. J Invest Dermatol Symp Proc 1999;4:239.
140. Freyschmidt-Paul P, Metz S, Sundberg JP, Happle R, Hoffmann R: Induction of hair regrowth in C3H/HeJ alopecia areata by treatment with the topical immunosuppressant FK506. J Invest Dermatol 2000;114:871.
141. Freyschmidt-Paul P, Hoffmann R, Levin R, Sundberg JP, Happle R, McElwee KJ: Current and potential therapeutic agents for the treatment of alopecia areata. Cur Pharm Des 2001;7: 213-230.
142. Gardner SP, Freyschmidt-Paul P, Hoffmann R, Sundberg JP, Happle R, Linsey NJ, Tobin DJ: Normalisation of hair follicle morphology in C3H/HeJ alopecia areata mice after treatment with squaric acid dibutylester. Eur J Dermatol 2000;10:443-450.
143. Ahmad W, Faiyaz U, Brancolini V, Tsou HC, Haque Su, Lam H, Alta VM, Owen J, deBlaquiere M, Frank J, Cserhalmi-Friedman PB, Leask A, McGrath JA, Peacocke M, Ahmad M, Ott J, Christiano AM: Alopecia universalis associated with a mutation in the human hairless gene. Science 1998;279:720-724.
144. Sundberg JP, Dunstan RW, Compton JG: Hairless Mouse, HRS/J hr/hr. Heidelberg, Springer-Verlag, 1989.
145. rh) mutations, chromosome 14; in Sundberg JP: Handbook of Mouse Mutations with Skin and Hair Abnormalities: Animal Models and Biomedical Tools. Boca Raton, CRC Press, 1994, pp 291-312.
146. Sundberg JP, Price VH, King LE: The 'hairless' gene in mouse and man. Arch Dermatol 1999;135:718-720.
147. Ahmad W, Panteleyev A, Sundberg JP, Christiano AM: Molecular basis for the rhino-8J mouse mutation: a nonsense mutation in the mouse hairless gene. Genomics 1998;53:383-386.
148. Christiano AM, Irvine A, McGrath JA, Ahmad M, Henson-Apollonio V, Sundberg JP, hmad W: Molecular pathology of papular atrichia: hairless gene mutations in humans and rhino mice. Third International Alopecia Areata Workshop, Washington, 1998.
149. rh-Y) phenotype: severe skin abnormalities and female reproductive defects associated with an insertion in the hairless gene. Exp Dermatol 1998;7:281-288.
150. rh-Chr) phenotype: a nonsense mutation in the mouse hairless gene. Exp Dermatol 1998;7:298-301.
151. Panteleyev AA, Paus R, Ahmad W, Sundberg JP, Christiano AM: Molecular and functional aspects of the hairless (hr) gene in laboratory rodents and humans. Exp Dermatol 1998;7:249-267.
152. Ahmad W, Panteleyev AA, Christiano AM: The molecular basis of congenital atrichia in humans and mice: mutations in the hairless gene. J Invest Dermatol Symp Proc 1999;4:240-243.
153. McElwee KJ, Boggess D, King LE, Sundberg JP: Alopecia areata versus juvenile alopecia in C3H/HeJ mice: tools to dissect the role of inflammation in focal alopecia. Exp Dermatol 1999;8:354-355.
154. Bullard DC, Scharffetter-Kochanek K, McArthur MJ, Chosay JG, McBride ME, Montgomery CA, Beaudet AL: A polygenic mouse model of psoriasiform skin disease in CD18-deficient mice. Proc Natl Acad Sci USA 1996;93:2116-2121.
155. McElwee KJ, Silva K, Beamer WG, King LE, Sundberg JP: Melanocyte and gonad activity as potential modifying factors in C3H/HeJ mouse alopecia areata. Exp Dermatol 2001;10:420-429.
156. Oh HS, Smart RC: An estrogen receptor pathway regulates the telogen-anagen hair follicle transition and influences epidermal differentiation. Proc Natl Acad Sci USA 1996;93: 12525-12530.
157. Stenn KS, Paus R, Filippi M: Failure of topical estrogen receptor agonists and antagonists to alter murine hair follicle cycling. J Invest Dermatol 1998;110:95.
158. Smart RC, Oh H-S, Robinette CL: Effects of 17-B-Estradiol and ICI 182 780 on hair growth in various strains of mice. J Invest Dermatol Symp Proc 1999;4:285-289.
159. Ohnemus U, Uenalan M, Inzunza J, Gustafsson JA, Paus R: The hair follicle as an estrogen target and source. Endocr Rev 2006;27:677-706.
160. Gardner SH: The role of autoantibodies to hair follicles in alopecia areata. Thesis, University of Bradford, 2001.
161. Sundberg JP, Orlow SJ, Sweet HO, Beamer WG: The adrenocortical dysplasia (acd) mutation, Chromosome 8; in Sundberg JP: Handbook of Mouse Mutations with Skin and Hair Abnormalities: Animal Models and Biomedical Tools. Boca Raton, CRC Press, 1994, pp 159-164.
162. Epidemiological evidence of the association between lichen planus and two immune-related diseases: alopecia areata and ulcerative colitis. Gruppo Italiano Studi Epidemiologici in Dermatologia. Arch Dermatol 1991;127:688-691.
163. Treem WR, Veligati LN, Rotter JI, Targan SR, Hyams JS: Ulcerative colitis and total alopecia in a mother and her son. Gastroenterology 1993;104:1187-1191.
164. Brandwein SL, McCabe RP, Cong Y, Waites KB, Ridwan BU, Dean PA, Ohkusa T, Birkenmeier EH, Sundberg JP, Elson EO: Spontaneously colitic C3H/HeJBir mice demonstrate selective antibody reactivity to antigens of the enteric bacterial flora. J Immunol 1997;159:44-52.
165. Gilhar A, Ullmann Y, Berkutzki T, Assy B, Kalish R: Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice. J Clin Invest 1998;101:62-67.
166. Zoller M, McElwee KJ, Engel P, Hoffmann R: Transient CD44 variant isoform expression and reduction in CD4+/CD25+ regulatory T cells in C3H/HeJ mice with alopecia areata. J Invest Dermatol 2002;118:983-992.
167. McElwee KJ, Silva F, Boggess D, Bechtold L, King, LE Jr, Sundberg JP: Alopecia areata in C3H/HeJ mice involves leukocyte-mediated root sheath disruption in advance of overt hair loss. Vet Pathol 2003;40:643-650.
168. Hara M, Kingsley CI, Niimi M, Read S, Turvey SE, Bushell AR, Morris PJ, Powrie F, Wood KJ: IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 2001;166:3789-3796.
169. Kumanogoh A, Wang X, Lee I, Watanabe C, Kamanaka M, Shi W, Yoshida K, Sato T, Habu S, Itoh M, Sakaguchi N, Sakaguchi S, Kikutani H: Increased T cell autoreactivity in the absence of CD40-CD40 ligand interactions: a role of CD40 in regulatory T cell development. J Immunol 2001; 166:353-360.
170. Tang L, Lui H, Sundberg JP, Bissonnette R, McLean DI, Shapiro J: Restoration of hair growth with topical diphencyporne in mouse and rat models of alopecia areata. J Am Acad Dermatol 2003;49:1013-1019.
171. Freyschmidt-Paul P, Seiter S, Zoller M, Konig A, Zeigler A, Sundberg JP, Happle R, Hoffmann R: Treatment with an anti-CD44v10-specific antibody inhibits the onset of alopecia areata in C3H/HeJ mice. J Invest Dermatol 2000;115:653-657.
172. Grabbe S, Varga G, Beissert S, Steinert M, Pendl G, Seeliger S, Bloch W, Peters T, Schwarz T, Sunderkotter C, Scharffetter-Kochanek K: B2 integrins are required for skin homing of primed T cells but not for priming naive T cells. J Clin Invest 2002;109:183-192.
173. Borson ND, Strausbauch MA, Kennedy RB, Oda RP, Landers JP, Wettstein PJ: Temporal sequence of transcription of perforin, fas ligand, and tumor necrosis factor-a genes in rejecting skin allografts. Transplantation 1999;67:672-680.
174. Dieleman LA, Elson CO, Tennyson GS, Beagley KW: Kinetics of cytokine expression during healing of acute colitis in mice. Am J Physiol 1996;271:G130-G136.
175. Hubner G, Brauchle M, Smola H, Madlener M, Fassler R, Werner S: Differential regulation of pro-inflammatory cytokines during wound healing in normal and glucocorticoid-treated mice. Cytokine 1996;8:548-556.
176. Parenteau GL, Doherty GM, Peplinskin GR, Tsung K, Norton JA: Prolongation of skin allografts by recombinant tumor necrosis factor and interleukin-1. Ann Surg 1995;221:572-578.
177. Cumberbatch M, Kimber I: Dermal tumour necrosis factor-α induces dendritic cell migration to draining lymph nodes, and possibly provides one stimulus for Langerhans' cell migration. Immunology 1992;75:257-263.
178. Cumberbatch M, Fielding I, Kimber I: Modulation of epidermal Langerhans' cell frequency by tumour necrosis factor-α. Immunology 1994;81:395-401.
179. Cotran RS, Pober JS: Cytokine-endothelial interactions in inflammatory immunity and vascular injury. J Am Soc Nephrol 1990;1:225-235.
180. Poper JS, Cotran RS: Cytokines and endothelial cell biology. Physiol Rev 1990;70:427-451.
181. Kainulainen V, Nelimarkka L, Jarvelainen H, Laato M, Jalkanen M, Elenius K: Suppression of syndecan-1 expression in endothelial cells by tumor necrosis factor-α. J Biol Chem 1996;271:18759-18766.
182. Slowik MR, DeLuca LG, Fiers W, Pober JS: Tumor necrosis factor activates human endothelial cells through the p55 tumor necrosis factor but the p75 receptor contributes to activation at low tumor necrosis factor concentration. Am J Pathol 1993;143:1724-1730.
183. Galbraith GMP, Pandey JP: Tumor necrosis factor α (TNF-α) gene polymorphism in alopecia areata. Hum Genet 1995;96:433-436.
184. Bugeon L, Dallman MJ: Costimuation of T cells. Am J Respir Crit Care Med 2000;162:S164-S168.
185. Sievenhaar F, Sharov AA, Peters EM, Sharova TY, Syska W, Mardaryev AN, Freyschmidt-Paul P, Sundberg JP, Maurer M, Botchkarev VA: Substance P as an immunomodulatory neuropeptide in a mouse model for autoimmune hair loss (alopecia areata). J Invest Dermatol 2007;127:1389-1497.
186. McElwee KJ, Freyschmidt-Paul P, Hoffmann R, Kissling S, Hummel S, Vitacolonna M, and Zoller M: Transfer of CD8+ cells induces localized hair loss whereas CD4+/CD25- cells promote systemic alopecia areata and CD4+/CD25- cells blockade disease onset in the C3H/HeJ mouse model. J Invest Dermatol 2005;124:947-957.
187. Tobin DJ, Olivry T, Sundberg JP, Boggess D, King LE, Bystryn J-C: Hair follicle-specific antibodies in mammalian species with alopecia areata. J Invest Dermatol 1997;108:654.
188. Kuwano Y, Fujimoto M, Watanabe R, Asashima N, Nakashima H, Ohno H, Yano S, Yazawa N, Okochi H, Tamaki K: Serum anti-Fcgamma receptor autoantibodies in patients with alopecia areata. Arch Dermatol Res 2007;298:493-498.
189. Sundberg JP, Boggess D, Silva KA, McElwee KJ, King LE, Li R, Churchill G, Cox GA: Major locus on mouse chromosome 17 and minor locus on chromosome 9 are linked with alopecia areata in C3H/HeJ mice. J Invest Dermatol 2003;120:771-775.
190. Sundberg JP, Silva KA, Li R, King LE, Cox GA: Adult onset alopecia areata is a complex polygenic trait in the C3H/HeJ mouse model. J Invest Dermatol 2004;123:294-297.
191. Freyschmidt-Paul P, Sundberg JP, Happle R, McElwee KJ, Metz S, Boggess D, Hoffmann R: Successful treatment of alopecia areata-like hair loss with the contact sensitizer squaric acid dibutylester (SADBE) in C3H/HeJ mice. J Invest Dermatol 1999;113:61-68.
192. Schafer N, Blaumeiser B, Becker T, Freudenberg-Hua Y, Eigelshoven HS, Schmael C, Lambert J, DeWeert J, Kruse R, Nothen MM, Betz RC: Investigation of the functional variant c.-169T->C of the Fc receptor-like 3 (FCRL3) gene in alopecia areata. Int J Immunogenet 2006;33: 393-395.
193. Colombe BW, Lou CD, Price VH: The genetic basis of alopecia areata: HLA associations with patchy alopecia areata versus alopecia totalis and alopecia universalis. J Invest Dermatol Symp Proc 1999;4:216-219.
194. deAndrade M, Jackow CM, Dahm N, Hordinsky M, Reveille JD, Duvic M: Alopecia areata in families: association with the HLA locus. J Invest Dermatol Symp Proc 1999;4:220-223.
195. Xiao FL, Zhou FS, Liu JB, Yan KL, Cui Y, Gao M, Liang YH, Sun LD, Zhou SM, Zhu YG, Zhang XJ, Yang S: Association of HLA-DQA1 and DQB1 alleles with alopecia areata in Chinese Hans. Arch Dermatol Res 2005;297:201-209.
196. Xiao FL, Yang S, Yan KL, Cui Y, Liang YH, Zhou FS, Du WH, Gao M, Sun LD, Fan X, Chen JJ, Wang PG, Zhu YG, Zhou SM, Zhang XJ: Association of HLA class I alleles with alopecia areata in Chinese Hans. J Dermatol Sci 2006;41:109-119.
197. Marques Da Costa C, Dupont E, VanderCruys M, Andrien M, Hidajat M, Song M, Stene JJ: Earlier occurrence of severe alopecia areata in HLA-DRB1*11-positive patients. Dermatology 2006;213:12-14.
198. Tarlow JK, Clay FE, Cork MJ, Blakemore AI, McDonagh AJ, Messenger AG, Duff GW: Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene. J Invest Dermatol 1994;103:387-390.
199. Galbraith GM, Palesch Y, Gore EA, Pandey JP: Contribution of interleukin 1β and KM loci to alopecia areata. Hum Hered 1999;49:85-89.
200. Tazi-Ahnini R, McDonagh AJ, Cox A, Messenger AG, Britton JE, Ward SJ, Bavik CO, Duff GW, Cork MJ: Association analysis of IL1A and IL1B variants in alopecia areata. Heredity 2001;87:215-219.
201. Cox A, Camp NJ, Nicklin MJH, diGiovine FS, Duff GW: An analysis of linkage disequilibrium in the interleukin-1 gene cluster, using a novel grouping method for multiallelic markers. Am J Hum Genet 1998;62:1180-1188.
202. Galbraith GMP, Pandey JP: Km1 allotype associated with one subgroup of alopecia areata. Am J Hum Genet 1989;44:426-428.
203. Dugoujon JM, Guitard E, Senegas MT: Gm and Km allotypes in autoimmune diseases. G Ital Cardiol 1992;22:85-95.
204. Dugoujon JM, Cambon-Thomsen A: Immunoglobulin allotypes (GM and KM) and their interactions with HLA antigens in autoimmune diseases: a review. Autoimmunity 1995;22:245-260.
205. Tazi-Ahnini R, McDonagh A, diGiovine F, Messenger A, Amadou C, Cox A, Duff G, Cork M: Structure and polymorphism of the human gene for the interferon-induced p78 protein (MX1): alopecia areata association with the Down syndrome region. J Invest Dermatol 2000;114:827.
206. Gilhar A, Shalaginov R, Assy B, Serafimovich S, Kalish RS: Alopecia areata is a T-lymphocyte mediated autoimmune disease: lesional human T-lymphocytes transfer alopecia areata to human skin grafts on SCID mice. J Invest Dermatol Symp Proc 1999;4:207-210.
207. Tobin DJ, Gardner SH, Luther PB, Dunston SM, Lindsey NJ, Olivry T: A natural canine homologue of alopecia areata in humans. Br J Dermatol 2003;149:938-950.
208. Noli C, Toma S: Three cases of immune-mediated adnexal skin disease treated with cyclosporine. Vet Dermatol 2006;17:85-92.
209. Conroy JD: An overview of immune-mediated mucocutaneous diseases in the dog and cat. II. Other diseases based on immunologic mechanisms. Am J Dermatopathol 1983;5:595-599.
210. Colombo S, Keen JA, Brownstein DG, Rhind SM, McGorum BC, Hill PB: Alopecia areata with lymphocytic mural folliculitis affecting the isthmus in a thoroughbred mare. Vet Dermatol 2004;15:260-265.
211. Shresta S, Smyth JR, Erf GF: Profiles of pulp infiltrating lymphocytes at various times throughout feather regeneration in Smyth line chickens with vitiligo. Autoimmunity 1997;25:193-201.
212. Wick G, Andersson L, Hala K, Gershwin ME, Selmi C, Erf GF, Lamont SJ, R RS: Avian models with spontaneous autoimmune diseases. Adv Immunol 2006;92:71-117.
213. McElwee KJ, Boggess D, Olivry T, Oliver RJ, Whiting D, Tobin JD, Bystryn J-C, King LE, Sundberg JP: Comparison of alopecia areata in human and nonhuman mammalian species. Pathobiology 1998;66:90-107.